By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ventana Medical Systems, Inc. 

1910 Innovation Park Drive

Tucson  Arizona  85755  U.S.A.
Phone: 520-887-2155 Fax: 520-229-4207



Company News
Cancer Genetics (CGIX) Partners With Ventana Medical Systems (VMSI), A Member Of The Roche Group (RHHBY) To Ensure Market Access To Predictive Biomarker Test For New mmuno-Oncology (IO) Therapy For Advanced Bladder Cancer 5/15/2017 9:01:44 AM
Transgenomic, Inc. (TBIO) And Ventana Medical Systems (VMSI) Complete Data Sharing Agreement 9/22/2016 11:38:25 AM
Horizon Discovery Ltd. And Ventana Medical Systems (VMSI) Sign Co-Development Agreement For Reference Standards 9/1/2016 1:18:41 PM
Ventana Medical Systems (VMSI) Release: Latest Developments In Cancer Research And Treatment Explored By Top Global Scientists At Tucson Symposium 2/8/2016 9:26:15 AM
Ventana Medical Systems (VMSI) Wins FDA Nod for the First Fully Automated IHC Companion Diagnostic to ID Lung Cancer Patients Eligible for XALKORI 6/15/2015 5:57:10 AM
Halozyme Therapeutics, Inc. (HALO), Ventana Medical Systems, Inc. (VMSI) Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5/27/2015 6:46:57 AM
Ventana Medical Systems, Inc. (VMSI) And Astellas Pharma Inc. (ALPMY) Join Forces To Leverage Novel Companion Diagnostic Tests For Targeted Cancer Treatments 4/14/2015 9:16:33 AM
Ventana Medical Systems, Inc. (VMSI) Release: Global Scientific Collaborators To Explore Latest Pathology And Oncology Advancements At Tucson Symposium 3/3/2015 11:03:08 AM
Ventana Medical Systems, Inc. (VMSI) Seeks FDA Premarket Approval For ALK IHC Companion Diagnostic To Benefit Lung Cancer Patients 1/21/2015 10:02:06 AM
Ventana Medical Systems, Inc. (VMSI) Announces Collaboration To Develop Companion Diagnostics For ImmunoGen, Inc. (IMGN)'s Targeted Anticancer Agents 10/28/2014 9:18:11 AM